Related Experiment Video
Updated: May 12, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
Comparison of artificial intelligence-generated and physician-generated patient education materials on early diabetic
Miaomiao Cheng1, Qi Zhang2, Hua Liang1
1Qilu Hospital of Shandong University, Department of Nephrology, Jinan, Shandong, China.
Background:
Diabetic kidney disease (DKD) is a common and serious complication of diabetes mellitus and has become the most important cause of end-stage renal disease (ESRD). In light of the rising prevalence of diabetes, there is a growing imperative for the early detection and intervention of DKD. With the rapid development of artificial intelligence (AI) technologies, its potential applications in patient education are receiving increasing attention, especially large language models (LLMs). The aim of this study was to evaluate the quality of LLMs-generated patient education materials (PEMs) for early DKD and to explore its feasibility in patient education.
Methods:
Four LLMs (ERNIE Bot 4.0, GPT-4o, ChatGLM4, and ChatGPT-o1) were selected for this study to generate PEMs. Among them, ERNIE Bot 4.0, GPT-4o, and ChatGLM4 generated 2 versions of PEMs based on American Diabetes Association(ADA) guidelines and without ADA guidelines, respectively. ChatGPT-o1 only generated a PEM without ADA guidelines. An experienced physician wrote a PEM based on ADA guidelines. All materials were assessed using a Likert scale which covered the dimensions of accuracy, completeness, safety, and patient comprehensibility. A total of 7 medical experts (including nephrologists and endocrinologists) and 50 diabetic patients were invited to evaluate the study. We recorded basic information on the patient evaluators.
Results:
Experts evaluated PEMs from ERNIE Bot 4.0, GPT-4o, ChatGLM4, and ChatGPT-o1, plus physician-sourced PEM. Results showed ERNIE Bot 4.0's non-guideline PEM and physician-sourced PEM were the top two. Patient assessments of the 2 top-scoring PEMs found that the ERNIE Bot 4.0's non-guideline PEM performed as well as, if not slightly better than, the physician-sourced PEM in terms of patient comprehensibility, completeness, and safety. In addition, the non-guideline-based PEM was preferred for patients with a history of diabetes longer than 5 years and for patients with proteinuria. Surprisingly, GPT-4o and ChatGLM4's non-guideline PEMs outperformed guideline-based ones.
Conclusion:
The LLMs-sourced PEMs, especially the ERNIE Bot 4.0's non-guideline PEM for early DKD, performed comparably to the physician-sourced PEM in terms of accuracy, completeness, safety, and patient comprehensibility, and exerted a high degree of feasibility. AI may show the potential for broader applications in patient education in the near future.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Antihypertensive Drugs: Direct Renin Inhibitors
Diabetes Mellitus: Type 2 and Gestational
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System